Stay updated on Aurinia Pharmaceuticals Press Releases
Sign up to get notified when there's something new on the Aurinia Pharmaceuticals Press Releases page.

Latest updates to the Aurinia Pharmaceuticals Press Releases page
- Check4 days agoChange DetectedCopyright year in the page footer updated from 2025 to 2026. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check62 days agoChange DetectedA new press release announcing Aurinia's financial results for the three and nine months ended September 30, 2025, and an update on recent business progress was added (dated November 3, 2025 and November 4, 2025). Two older press releases—one about participating in a conference and another about the AUR200 trial dosing—were removed.SummaryDifference3%

- Check83 days agoChange DetectedReplace a past financial results item with a forward-looking press update about upcoming data presentations for LUPKYNIS at major conferences.SummaryDifference8%

- Check91 days agoChange DetectedUpdate: new content highlights including growth, AUR200, Japan approval, and real-world data; older versioned headlines removed.SummaryDifference41%

- Check98 days agoChange DetectedUpdated corporate update: removes the Q2 results release notice from 2024 and adds a 2025 response post, signaling a shift in published company communications.SummaryDifference5%

- Check162 days agoChange DetectedAurinia Pharmaceuticals has updated its financial reporting date to July 31, 2025, while removing a previous announcement regarding participation in investor healthcare conferences scheduled for July 2, 2024.SummaryDifference6%

Stay in the know with updates to Aurinia Pharmaceuticals Press Releases
Enter your email address, and we'll notify you when there's something new on the Aurinia Pharmaceuticals Press Releases page.